200028: China National Accord Medicines Corporation Ltd. - Summary | Jitta

China National Accord Medicines Corporation Ltd.

CHN:200028

Price
HK$13.85
Loss Chance
43.1%
5.40JITTA SCORE
48.45%Under Jitta Line
Jitta Ranking
14 / 487
144 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (27)
Recent Business Performance (53)
Financial Strength (86)
Return to Shareholders (29)
Competitive Advantage (48)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
CapExVery Low
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Revenue and EarningRevenue decline from 2022-2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 3.79% in the last year
Key Stats
Jitta Score
Jitta Line
5.40
48.45%
4.24
> 1,000%
Health Care Distributors
5.31
1.54%
6.90
4.08%
5.40
82.02%
COMPANY DESCRIPTION
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers new and special drugs and medications for chronic diseases. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources, as well as chemical drugs, OTC drugs, and health products. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. China National Accord Medicines Corporation Ltd. was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.